IDEAYA Biosciences Enters Into Licensing Agreement With Jiangsu Hengrui for Cancer Drug Candidate SHR-4849
In This Article:
IDEAYA Biosciences (IDYA) said Sunday it has entered into an exclusive licensing agreement with Jian
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.